When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharma fights approval of Firdapse rival in Canada
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals (CPRX+1.3%) and Canada commercialization partner KYE Pharmaceuticals announce the filing of a proceeding in a Canadian federal court challenging Health Canada's approval of Medunik's Ruzurgi (amifampridine) for the treatment of Lambert-Eaton myasthenic syndrome.
More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news,